Layered double hydroxide nanoparticles as target-specific delivery carriers: Uptake mechanism and toxicity

Nanomedicine

Volumn 6, Issue 5, 2011, Pages 803-814

  Choi, Soo Jin ^a   Choy, Jin Ho ^b  

^a Seoul Women University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

layered double hydroxide; uptake behaviors; uptake mechanism toxicity

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HYDROTALCITE; HYDROXIDE; LAYERED DOUBLE HYDROXIDE; METHOTREXATE; NANOCARRIER; NANOPARTICLE; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; BIOMEDICINE; CHEMICAL COMPOSITION; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION; WEIGHT CHANGE;

ALUMINUM HYDROXIDE; ANIMALS; BIOLOGICAL TRANSPORT; DRUG CARRIERS; HUMANS; HYDROXIDES; MAGNESIUM HYDROXIDE; NANOPARTICLES;

EID: 79960966253     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.86     Document Type: Review

References (52)

1. Baes CF, Mesmer RE. The Hydrolysis of Cations (Vol.)., Wiley-Interscience, NY, USA (1976).
2. Cavani F, Trifiro F, Vaccari A. Hydrotalcite-type anionic clays: preparation, properties and applications. Catal. Today 11, 173-301 (1991).
3. Evans DG, Duan X. Preparation of layered double hydroxides and their applications as additives in polymers, as precursors to magnetic materials and in biology and medicine. Chem. Commun. 485-496 (2006).
4. Xu ZP, Stevenson GS, Lu CQ, Lu GQ, Bartlett PF, Gray PP. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J. Am. Chem. Soc. 128, 36-37 (2006). (Pubitemid 43100836)
5. y (m=1 and 2).Science280, 1589-1592 (1998).
6. Desigaux L, Belkacem MB, Richard P et al. Self-assembly and characterization of layered double hydroxide/DNA hybrids. Nano Lett. 6, 199-204 (2006). (Pubitemid 43382951)
7. Leroux F. Organo-modified anionic clays into polymer compared with smectite-type nanofiller: potential applications of the nanocomposites. J. Nanosci. Nanotechnol. 6, 303-315 (2006). (Pubitemid 44576185)
8. Choy JH, Choi SJ, Oh JM, Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci. 36, 122-132 (2007). (Pubitemid 46414158)
9. Ladewig K, Xu ZP, Lu GQ. Layered double hydroxide nanoparticles in gene and drug delivery. Expert. Opin. Drug Deliv. 6, 907-922 (2009).
10. Xu ZP, Walker TL, Liu KL, Cooper HM, Lu GQ, Bartlett PF. Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. Int. J. Nanomedicine 2, 163-174 (2007). (Pubitemid 47215017)
11. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem. Eng. Sci. 61, 1027-1040 (2006). (Pubitemid 41650188)
12. Choi SJ, Oh JM, Choy JH. Anticancer drug-layered double hydroxide nanohybrids as potent cancer chemotherapy agents. J. Phys. Chem. Solids 69, 1528-1532 (2008).
13. Choi SJ, Oh JM, Choy JH. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study. J. Nanosci. Nanotechnol. 10, 2913-2916 (2010).
14. Choy JH, Jung JS, Oh JM, Park M, Jeong J, Kang YK, Han OJ. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 25, 3059-3064 (2004). (Pubitemid 38210198)
15. Choy JH, Kwak SY, Jeong YJ, Park JS. Inorganic layered double hydroxides as nonviral vectors. Angew. Chem. Int. Ed. Engl. 39, 4042-4045 (2000).
16. Choy JH, Kwak SY, Park JS, Jeong YJ. Cellular uptake behavior of [g-P-32] labeled ATP-LDH nanohybrids. J. Mater. Chem. 11, 1671-1674 (2001).
17. Choy JH, Kwak SY, Park JS, Jeong YJ, Portier J. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 121, 1399-1400 (1999). (Pubitemid 29104078)
18. Choy JH, Son YH. Intercalation of vitamer into LDH and their controlled release properties. Bull. Kor. Chem. Soc. 25, 122-126 (2004).
19. Kim JY, Choi SJ, Oh JM, Park T, Choy JH. Anticancer drug-inorganic nanohybrid and its cellular interaction. J. Nanosci. Nanotechnol. 7, 3700-3705 (2007).
20. Kwak SY, Jeong YJ, Park JS, Choy JH. Bio-LDH nanohybrid for gene therapy. Solid State Ionics 151, 229-234 (2002).
21. Oh JM, Choi SJ, Lee GE, Han SH, Choy JH. Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand. Adv. Funct. Mater. 19, 1-8 (2009).
22. Wong Y, Markham K, Xu ZP et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 31, 8770-8779 (2010).
23. Oh JM, Choi SJ, Kim ST, Choy JH. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug. Chem. 17, 1411-1417 (2006).
24. Choi SJ, Oh JM, Choy JH. Human-related application and nanotoxicology of inorganic particles: complementary aspects. J. Mater. Chem. 18, 615-620 (2008).
25. Burzlaff A, Brethauer S, Kasper C, Jackisch BO, Scheper T. Flow cytometry: interesting tool for studying binding behavior of DNA on inorganic layered double hydroxide (LDH).Cytometry A 62, 65-69 (2004). (Pubitemid 39473455)
26. Peterson CL, Perry DL, Masood H et al. Characterization of antacid compounds containing both aluminum and magnesium. I. Crystalline powders. Pharm. Res. 10, 998-1004 (1993). (Pubitemid 23211422)
27. Xu ZP, Niebert M, Porazik K et al. Subcellular compartment targeting of layered double hydroxide nanoparticles. J. Control. Release 130, 86-94 (2008).
28. Berry CC, Wells S, Charles S, Aitchison G, Curtis AS. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25, 5405-5413 (2004). (Pubitemid 38586755)
29. Fisichella M, Dabboue H, Bhattacharyya S et al. Uptake of functionalized mesoporous silica nanoparticles by human cancer cells. J. Nanosci. Nanotechnol. 10, 2314-2324 (2010).
30. Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed. Engl. 45, 577-581 (2006). (Pubitemid 43121447)
31. Kam NWS, Dai HJ. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J. Am. Chem. Soc. 127, 6021-6026 (2005). (Pubitemid 40577658)
32. Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine (Lond.) 5, 89-97 (2010).
33. Thurn KT, Arora H, Paunesku T et al. Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine 7, 123-130 (2011).
34. Oh JM, Choi SJ, Lee GE, Kim JE, Choy JH. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem. Asian J. 4, 67-73 (2009).
35. Choi SJ, Oh JM, Choy JH. Safety aspect of inorganic layered nanoparticles: size-dependency in vitro and in vivo. J. Nanosci. Nanotechnol. 8, 5297-5301 (2008).
36. Mousavi SA, Malerod L, Berg T, Kjeken R. Clathrin-dependent endocytosis. Biochem. J. 377, 1-16 (2004). (Pubitemid 38114427)
37. Choi SJ, Choi G, Oh JM, Oh YJ, Park MC, Choy JH. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance. J. Mater. Chem. 20, 9463-9469 (2010).
38. Shanley JD, Debs RJ. The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro. Antiviral Res. 11, 99-106 (1989). (Pubitemid 19106424)
39. Kim CH, Park YS, Chung KN, Elwood PC. Sorting and function of the human folate receptor is independent of the caveolin expression in Fisher rat thyroid epithelial cells. J. Biochem. Mol. Biol. 35, 395-402 (2002).
40. Bharali DJ, Lucey DW, Jayakumar H, Pudavar HE, Prasad PN. Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J. Am. Chem. Soc. 127, 11364-11371 (2005). (Pubitemid 41176898)
41. Choi SJ, Oh JM, Choy JH. Biocompatible ceramic nanocarrier for drug delivery with high efficiency. J. Ceram. Soc. Jpn 117, 543-549 (2009).
42. Choi SJ, Oh JM, Choy JH. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 103, 463-471 (2009).
43. Dikalov SI, Dikalova AE, Mason RP. Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch. Biochem. Biophys. 402, 218-226 (2002). (Pubitemid 34848639)
44. Adibhatla RM, Hatcher JF. Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 41, 560-567 (2008).
45. Li Y, Liu D, Ai H et al. Biological evaluation of layered double hydroxides as efficient drug vehicles. Nanotechnology 21, 105101 (2010).
46. Choi SJ, Oh JM, Park T, Choy JH. Cellular toxicity of inorganic hydroxide nanoparticles. J. Nanosci. Nanotech. 7, 4017-4020 (2007).
47. Kobayashi J, Kizu R, Sugiyama H. Influence of polyaromatic hydrocarbons and heavy metals on a thyroid carcinoma cell line. J. Health Sci. 51, 202-206 (2005). (Pubitemid 40628467)
48. Lanone S, Rogerieux F, Geys J et al. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part. Fibre Toxicol. 6, 14 (2009).
49. Zhu X, Zhu L, Duan Z, Qi R, Li Y, Lang Y. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 43, 278-284 (2008).
50. Baek M, Kim IS, Yu J, Chung HE, Choy JH, Choi SJ. Effect of different forms of anionic nanoclays on cytotoxicity. J. Nanosci. Nanotechnol. 11, 1803-1806 (2011).
51. Tongamp W, Zhang Q, Saito F. Mechanochemical route for synthesizing nitrate form of layered double hydroxide. Powder Technol. 185, 43-48 (2008). (Pubitemid 351671812)
52. Kwak SY, Kriven WM, Wallig MA, Choy JH. Inorganic delivery vector for intravenous injection. Biomaterials 25, 5995-6001 (2004). (Pubitemid 38747022)